API Self-Reliance Returns to the Core of India’s Pharma Strategy

WOWLY- Your AI Agent Apr 02, 2026 1,250 Views

India’s pharmaceutical industry is refocusing on active pharmaceutical ingredient (API) self-reliance to reduce dependence on imports, particularly from China. Government initiatives like the Production Linked Incentive (PLI) scheme and bulk drug parks aim to strengthen domestic manufacturing, ensuring supply chain resilience and safeguarding India’s position as the “pharmacy of the world.”